Moreover, a recent EBCTCG meta-analysis including more than 62,000 HR+/HER2− eBC patients treated with adjuvant endocrine treatment confirmed that PgR status represents an independent prognostic factor in the first 5 years after BC diagnosis [16]. Here, PGR is linked to breast cancer.